Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis

被引:83
作者
Hsiao, JR
Jin, YT
Tsai, ST
Shiau, AL
Wu, CL
Su, WC
机构
[1] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 701, Taiwan
[2] Natl Cheng Kung Univ Hosp, Dept Otolaryngol, Tainan 704, Taiwan
[3] Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan 704, Taiwan
[4] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan
[5] Natl Cheng Kung Univ, Coll Med, Dept Biochem, Tainan 701, Taiwan
[6] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 704, Taiwan
关键词
signal transducers and activators of transcription (STAT); nasopharyngeal carcinoma (NPC); Epstein-Barr virus (EBV);
D O I
10.1038/sj.bjc.6601003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Constitutively activated signal transducers and activators of transcription (STAT) factors, in particular STAT1, STAT3 and STAT5, have been demonstrated in a variety of human tumours and cancer cell lines. However, data on the expression of these STATs in nasopharyngeal carcinoma (NPC) are limited. In this study, the expression patterns of STAT1, STAT3 and STAT5 were immunohistochemically examined on the archival specimens from 61 patients with NPC. Staining results of each STATs were then correlated with the clinical parameters and prognosis of these patients. The results showed that constitutive activation of STAT3 and STAT5 was detected in the majority, 70.5 and 62.3%, respectively, of the 61 tumour specimens. Furthermore, coexpression of activated STAT3 and STAT5 was found in 54.1% of the specimens. In contrast, constitutive activated STAT1 could only be detected in 8 (13.1%) cases. Surprisingly, following radiotherapy, patients with constitutive STAT5 activation, or activation of both STAT3 and STAT5, had better disease-free survival and overall survival than those without activated STAT5. To our knowledge, this is the first report providing the overall expression patterns and prognostic significance of specific STATs in NPC.
引用
收藏
页码:344 / 349
页数:6
相关论文
共 34 条
[31]  
Tsai ST, 1996, CANCER, V77, P231, DOI 10.1002/(SICI)1097-0142(19960115)77:2<231::AID-CNCR2>3.3.CO
[32]  
2-C
[33]   STAT proteins: novel molecular targets for cancer drug discovery [J].
Turkson, J ;
Jove, R .
ONCOGENE, 2000, 19 (56) :6613-6626
[34]   Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3 gamma [J].
Wong, LH ;
Krauer, KG ;
Hatzinisiriou, I ;
Estcourt, MJ ;
Hersey, P ;
Tam, ND ;
Edmondson, S ;
Devenish, RJ ;
Ralph, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (45) :28779-28785